Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Crossbow Therapeutics
1030 Massachusetts Avenue
Cambridge, MA 02138- Is this information wrong?
Education & Training
Brigham and Women's HospitalPost-Doctoral Fellowship, Hematologic malignancies, murine leukemia models, 2003 - 2008- Brigham and Women's HospitalFellowship, Hematopathology, 2001 - 2002
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1999 - 2001
Stony Brook University Health Sciences Center School of MedicineClass of 1999
Stony Brook University/Cold Spring Harbor LaboratoryPhD, Molecular Genetics and Microbiology, 1993 - 1997
Certifications & Licensure
MA State Medical License 2002 - 2025- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 3 citationsSRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.Warren, M., Matissek, S., Rausch, M., Panduro, M., Hall, R., Dulak, A., Brennan, D., Das Yekkirala, S., Koseoglu, S., Masia, R., Yang, Y., Reddy, N., Prenovitz, R., St...> ;Immunohorizons. 2023 May 1
- 30 citationsThe Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.Marisa O. Peluso, Ammar Adam, Caroline M. Armet, Li Zhang, O'connor Rachel W, Benjamin H. Lee, Andrew Lake, Emmanuel Normant, Scott C. Chappel, Jonathan A. Hill, Vito ...> ;Journal for Immunotherapy of Cancer. 2020 Apr 1
- 91 citationsPrevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.Siyuan Xia, Ruiting Lin, Lingtao Jin, Liang Zhao, Hee-Bum Kang, Yaozhu Pan, Shuangping Liu, Guoqing Qian, Zhiyu Qian, Evmorfia Konstantakou, Baotong Zhang, Jin-Tang Do...> ;Cell Metabolism. 2017 Feb 7
- Join now to see all
Grant Support
- Murine Models Of Activated FLT3 Receptor Tyrosine KinaseNational Cancer Institute2006–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
